Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James C Coons

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Pulmonary Circulation|May 11, 2016
Oral treprostinil for the treatment of pulmonary arterial hypertension in patients transitioned from parenteral or inhaled prostacyclins: case series and treatment protocolJames C Coons, Taylor Miller, Marc A Simon, et al.
Current Cardiology Reports|November 24, 2019
Pulmonary Arterial Hypertension: a Pharmacotherapeutic UpdateJames C Coons, Kristen Pogue, Andrew R Kolodziej, et al.
The Annals of Pharmacotherapy|August 18, 2005
Outcomes and costs of abciximab versus eptifibatide for percutaneous coronary interventionJames C Coons, Amy L Seybert, Melissa I Saul, et al.
The Annals of Pharmacotherapy|November 27, 2024
Utilizing Theoretical Domains Framework to Determine Barriers to Evidence-Based Recommendations in Non-Valvular Atrial FibrillationEvan White, Sandra L Kane-Gill, Sandeep Jain, et al.
American Heart Journal Plus : Cardiology Research and Practice|November 6, 2024
Medication optimization clinic decreases hospitalizations and mortality for patients with heart failure with reduced ejection fractionJames C Coons, Jennifer Kliner, Michael A Mathier, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 6, 2021
Use of Disproportionality Analysis to Identify Previously Unknown Drug-Associated Causes of Cardiac Arrhythmias Using the Food and Drug Administration Adverse Event Reporting System (FAERS) DatabaseLindsay N Moreland-Head, James C Coons, Amy L Seybert, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 12, 2022
Antiplatelet Therapy and Bleeding Outcomes With CYP2C19 GenotypingJames C Coons, James M Stevenson, Ami Patel, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 28, 2022
Apixaban as an alternative to warfarin for patients with a left ventricular assist deviceEdward T Horn, Emilee Baker, Jennifer Dolphin, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 8, 2017
Performance of Anti-Factor Xa Versus Activated Partial Thromboplastin Time for Heparin Monitoring Using Multiple NomogramsEmily Whitman-Purves, James C Coons, Taylor Miller, et al.
JHLT Open|June 9, 2025
Safety and pharmacokinetics of ralinepag, a novel oral prostacyclin receptor agonistAli Ataya, James C Coons, Natalie Patzlaff, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Pulmonary Circulation|May 11, 2016
Oral treprostinil for the treatment of pulmonary arterial hypertension in patients transitioned from parenteral or inhaled prostacyclins: case series and treatment protocolJames C Coons, Taylor Miller, Marc A Simon, et al.
Current Cardiology Reports|November 24, 2019
Pulmonary Arterial Hypertension: a Pharmacotherapeutic UpdateJames C Coons, Kristen Pogue, Andrew R Kolodziej, et al.
The Annals of Pharmacotherapy|August 18, 2005
Outcomes and costs of abciximab versus eptifibatide for percutaneous coronary interventionJames C Coons, Amy L Seybert, Melissa I Saul, et al.
The Annals of Pharmacotherapy|November 27, 2024
Utilizing Theoretical Domains Framework to Determine Barriers to Evidence-Based Recommendations in Non-Valvular Atrial FibrillationEvan White, Sandra L Kane-Gill, Sandeep Jain, et al.
American Heart Journal Plus : Cardiology Research and Practice|November 6, 2024
Medication optimization clinic decreases hospitalizations and mortality for patients with heart failure with reduced ejection fractionJames C Coons, Jennifer Kliner, Michael A Mathier, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 6, 2021
Use of Disproportionality Analysis to Identify Previously Unknown Drug-Associated Causes of Cardiac Arrhythmias Using the Food and Drug Administration Adverse Event Reporting System (FAERS) DatabaseLindsay N Moreland-Head, James C Coons, Amy L Seybert, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 12, 2022
Antiplatelet Therapy and Bleeding Outcomes With CYP2C19 GenotypingJames C Coons, James M Stevenson, Ami Patel, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 28, 2022
Apixaban as an alternative to warfarin for patients with a left ventricular assist deviceEdward T Horn, Emilee Baker, Jennifer Dolphin, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 8, 2017
Performance of Anti-Factor Xa Versus Activated Partial Thromboplastin Time for Heparin Monitoring Using Multiple NomogramsEmily Whitman-Purves, James C Coons, Taylor Miller, et al.
JHLT Open|June 9, 2025
Safety and pharmacokinetics of ralinepag, a novel oral prostacyclin receptor agonistAli Ataya, James C Coons, Natalie Patzlaff, et al.
Pageof 8